September 8, 2026 — Knightscope (NASDAQ: KSCP), a security technology company building an Autonomous Security Force, announced that Founder, Chairman and CEO William Santana Li will present at a Tribe Public webinar and Q&A event titled “Building America’s Autonomous Security Force With AI, Robotics, and Humans” on Sept. 10 at 11:30 a.
September 8, 2026 — Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company combining immunology therapeutic development with a revenue-generating contract development and manufacturing organization (“CDMO”), announced a strategic refocusing of its R&D portfolio following the Aug. 31 expiration and termination of its option and license arrangements with PinCell S.
September 8, 2026 — Roth Capital Partners is scheduled to host and sponsor more than a dozen investor events from September 2026 through June 2027, including seven ROTH-hosted conferences focused on healthcare, nuclear technology, solar and storage, technology and other growth sectors. Upcoming hosted events include the 5th Annual ROTH Healthcare Opportunities Conference on Sept.
September 8, 2026 — Wearable Devices (NASDAQ: WLDS), a pioneer in artificial intelligence (“AI”)-powered touchless sensing wearables, announced that it will showcase its neural sensing layer for Physical AI and humanoid robotics at Physical AI 2026 in Tel Aviv. The company technology is designed to complement vision-based training data with synchronized signals associated with human movement, muscle activation and intent.
September 8, 2026 — Faraday Future (NASDAQ: FFAI) is a U. S.
September 8, 2026 — Cyabra (NASDAQ: CYAB) is an AI-powered narrative intelligence company that helps national security and defense organizations, government agencies, brands, communications agencies, and global enterprises restore trust and authenticity online by analyzing manipulated content, coordinated behaviors, and inauthentic actors. The platform helps teams understand who is operating, how activity is amplified, and where coordinated activity is shaping perception, translating evidence into clear mitigation steps.
September 8, 2026 — BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.
September 8, 2026 — OS Animal Health is a wholly owned subsidiary of OS Therapies Inc. (NYSE American: OSTX) dedicated to improving outcomes for pets with cancer.
September 8, 2026 — Impala Platinum, a South African giant in the global PGM industry, has paid out enhanced dividends to its shareholders after enjoying a year of bulked-up metal prices as PGMs saw their prices soar in a reversal of multiple years of dismal prices. Analysts are watching to see how other major platinum producers like Platinum Group Metals Ltd.
September 8, 2026 — BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.
September 8, 2026 — NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage developer of antiviral drugs, announced that its phase II clinical trial evaluating NV-387 Oral Gummies as a treatment for Bundibugyo ebolavirus and other Ebola viruses in the Democratic Republic of Congo (“DRC”) has been registered in the Pan African Clinical Trials Registry under identification number PACTR202608748555077.
September 8, 2026 — Datavault AI (NASDAQ: DVLT), an Artificial Intelligence Platform (“AIP”) company, announced that its Information Data Exchange(R) (“IDE(R)”), NIL Vault (“NILv(TM)”) and American Political Exchange (“APEX(TM)”) are scheduled to launch Sept. 15, marking the company transition from infrastructure development toward commercial deployment.
September 8, 2026 — Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced that it received a Sept. 2 Notice of Publication from the U.
September 8, 2026 — Greenland Mines (NASDAQ: GRML) announced a series of corporate milestones as it transitions into a focused rare earths and critical minerals company, including plans to spin off its biotechnology division in the fourth quarter of 2026. Nasdaq has formally approved the company application relating to its March 2026 transaction, resolving prior deficiencies and bringing Greenland Mines into full compliance with listing requirements.
September 8, 2026 — This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
September 8, 2026 — This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.
September 8, 2026 — This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.
September 8, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.
September 8, 2026 — American Fusion (OTC: AMFN), developer of the proprietary Texatron(TM) Fusion Engine(TM), reported the filing of 30 additional U. S.
September 8, 2026 — The LGL Group (NYSE American: LGL) is a publicly traded holding company that acquires, owns and builds businesses and makes strategic investments, with an emphasis on critical technologies. LGL Group conducts its business through two complementary activities: Platform Operations and Merchant Investment.